The 91220 mCare 300

Spacelabs Healthcare is a growing group of companies now operating under one new name. Earlier companies incorporated under this name include Spacelabs Medical, Del Mar Reynolds, Blease, Hertford Cardiology and Spacelabs Medical Data.

Photo: The 91220 mCare 300

The company focuses on products for patient monitoring and connectivity; anaesthesia and ventilation; diagnostic cardiology and clinical trials, with service, supplies and accessories for all products.


Spacelabs Healthcare has launched a new device for the bedside – the mCare 300 Vital Signs Monitor. ‘This is intuitive, immediate, portable and flexible for any care environment, the company reports. ‘Its clean design makes the mCare 300 easy to use, fast, flexible and lightweight – it weights just 4.1 kgs (9 lbs.), and has one battery.  For immediate care assessment, the common functions are controlled by a single button. The new monitor delivers essential parameters – ECG, respiration, Sp02, NIBP and dual temperature. Higher acuity parameters can be added with optional invasive blood pressure and EtC02.

17.11.2006

More on the subject:

Related articles

Photo

News • Nanozyme-empowered responsive hydrogel

Smart bandage could heal and monitor wounds at the same time

Australian researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also delivering healing agents in one simple, scalable platform.

Photo

News • In utero monitoring during surgery

New probe tracks baby's health in the uterus

Northwestern University researchers have developed the first device that can continuously track a fetus’s vital signs while still in the uterus — a feat that previously has not been possible.

Photo

News • iCTG for resource-constrained settings

Mobile fetal heart monitoring linked to fewer newborn deaths

Introducing mobile iCTG dramatically improves the detection of fetal heart rate abnormalities and strengthens perinatal outcomes - even in resource-constrained environments, a new study shows.

Subscribe to Newsletter